ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $1,680,000 | -64.5% | 480,000 | 0.0% | 0.88% | -56.6% |
Q1 2021 | $4,733,000 | -9.0% | 480,000 | 0.0% | 2.02% | -17.6% |
Q4 2020 | $5,203,000 | +5.2% | 480,000 | 0.0% | 2.44% | -3.6% |
Q3 2020 | $4,944,000 | -50.7% | 480,000 | 0.0% | 2.54% | -52.4% |
Q2 2020 | $10,022,000 | +113.7% | 480,000 | 0.0% | 5.33% | +79.2% |
Q1 2020 | $4,690,000 | -15.2% | 480,000 | 0.0% | 2.97% | +19.7% |
Q4 2019 | $5,530,000 | +111.4% | 480,000 | 0.0% | 2.48% | +107.0% |
Q3 2019 | $2,616,000 | -54.2% | 480,000 | 0.0% | 1.20% | -54.3% |
Q2 2019 | $5,707,000 | +126.9% | 480,000 | 0.0% | 2.62% | +141.8% |
Q1 2019 | $2,515,000 | +66.3% | 480,000 | 0.0% | 1.08% | +52.2% |
Q4 2018 | $1,512,000 | -47.9% | 480,000 | 0.0% | 0.71% | -34.3% |
Q3 2018 | $2,904,000 | +14.2% | 480,000 | 0.0% | 1.08% | +2.7% |
Q2 2018 | $2,544,000 | -8.6% | 480,000 | 0.0% | 1.06% | +32.0% |
Q1 2018 | $2,784,000 | +65.7% | 480,000 | 0.0% | 0.80% | +62.6% |
Q4 2017 | $1,680,000 | – | 480,000 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |